Clinical Trials

Soft Tissue and Bone Tumors

Recruitment stopped
Ongoing Recruitment

Ewing 2008 / EWING2008

(neoadjuvant, pädiatrisch)
Title:Phase 3, Open Label, Multi-centre, Randomised Controlled International Study in Ewing Sarcoma
Indication:Ewing's Sarcoma
Type of study:Phase III
Contact: Renate Sedlak (Study Nurse)
[renate.sedlak@med.uni-heidelberg.de]
Investigator: PD Dr. med. Gerlinde Egerer (Prüfer)
Trial Register: Die Studie ist bei den "U.S. National Institutes of Health" (ClinicalTrials.gov) registriert. Siehe NCT00987636
EudraCT: 2008-003658-13 (siehe EU klinisches Studienregister)

PMO-1601

(second-line, therapeutisch, p16 deletiert, CDKN2A/B deletiert)
Title:CDK4/6 Inhibition in Locally Advanced/Metastatic Chordoma (NCT-PMO-1601)
Indication:Chordoma
Type of study:Phase II
Contact: Margit Peters-Hornig (Kontaktperson)
[margit.peters-hornig@med.uni-heidelberg.de]
Investigator: Prof. Dr. Stefan Fröhling (Leiter klinische Prüfung)
Trial Register: Die Studie ist bei den "U.S. National Institutes of Health" (ClinicalTrials.gov) registriert. Siehe NCT03110744
EudraCT: 2016-004660-19 (siehe EU klinisches Studienregister)

CHONDROSARKOM (CSP12C)

(Schwerionentherapie, radiologisch)
Title:Randomised Trial of Proton vs. Carbon Ion Radiation Therapy in Patients With Low and Inter-mediate Grade Chondrosarcoma of the Skull Base, Clinical Phase III Study
Indication:Chondrosarcoma
Type of study:Phase III
Investigator: Prof. Dr. med. Jürgen Debus (Prüfer)
Trial Register: Die Studie ist bei den "U.S. National Institutes of Health" (ClinicalTrials.gov) registriert. Siehe NCT01182753
EudraCT: Not stated. Non-interventional studies and studies not controlled by the Medicines Act do not have a EudraCT number.

CHORDOM (HIT-1 / CH.P.12C)

(Schwerionentherapie, radiologisch)
Title:Randomised Trial of Proton vs. Carbon Ion Radiation Therapy in Patients With Chordoma of the Skull Base -Clinical Phase III Study
Indication:Chordoma
Type of study:Phase III
Contact: Renate Haselmann (Study Nurse)
[renate.haselmann@med.uni-heidelberg.de]
Investigator: Prof. Dr. med. Jürgen Debus (Prüfer)
Trial Register: Die Studie ist bei den "U.S. National Institutes of Health" (ClinicalTrials.gov) registriert. Siehe NCT01182779
EudraCT: Not stated. Non-interventional studies and studies not controlled by the Medicines Act do not have a EudraCT number.

IRON-2

Title:Intensity-modulated Radiotherapy With Integrated-boost in Patients With Spinal Bone Metastases
Indication:Neoplasm MetastasisNeoplasms, Second Primary
Type of study:Phase II
Contact: Dr. med. Tanja Sprave (Kontaktperson)
[tanja.sprave@med.uni-heidelberg.de]
Investigator: PD Dr. Dr. med. Harald Rief (Prüfer)
Trial Register: Die Studie ist bei den "U.S. National Institutes of Health" (ClinicalTrials.gov) registriert. Siehe NCT02832765
EudraCT: Not stated. Non-interventional studies and studies not controlled by the Medicines Act do not have a EudraCT number.